U.S. District Judge Sheri Polster Chappell mandated a settlement conference on November 20, 2025, in the insider trading case against former Humanigen CSO Dale Chappell, referring parties to non-assigned magistrate mediation after impasse in prior talks, escalating efforts to resolve the $38 million fraud claim without trial. Under Middle District of Florida’s Local Rule 2.2.2, the order—requiring good-faith attendance and confidential briefs five days prior—targets Chappell’s alleged sales of 3.8 million shares for $68 million in June-August 2021 while possessing nonpublic FDA rejection info on COVID drug Lenzilumab, per unsealed December 23, 2024, indictment (24-CR-243). For litigation trackers, Chappell’s directive—echoing her policy on all civil referrals—highlights ADR’s efficacy, with 75% resolution rates in FLMD, though failure risks $500,000 sanctions.
Case backdrop: Chappell—Humanigen’s ex-CSO and board member—allegedly exploited Rule 10b5-1 plans to avoid $38 million losses post-FDA denial announcement on September 9, 2021, tanking stock 50%, per DOJ. Status conference rescheduled to December 8 before Judge Karen M. Williams in Camden adds pressure, with mediation focusing on discovery disputes and expert stipulations under FRCP 16, as SEC seeks injunctions, disgorgement, penalties, and bars against Chappell and vehicles like Black Horse Capital. Technically, Chappell‘s hybrid format—virtual/in-person—mandates lead counsel presence, barring devices and enforcing silent mode, to streamline issues like baseless claims and evidence admissibility in the securities fraud suit (2:22-cv-05258).
Broader implications: this aligns with Virginia’s JSC program—launched 2003 for retired judges—and California’s mandatory conferences under CPLR 3408 for foreclosures, slashing dockets 20% via per diem vouchers. Risks: non-compliance invites Rule 37 sanctions, while 30-day objection windows allow mediation switches. As December deadlines loom, Chappell’s mandate—potentially averting 2026 trial—epitomizes judicial efficiency: conferences gateways to resolution in ADR’s evolving landscape, where mediation isn’t delay—it’s the diplomatic dodge for justice’s drawn-out duel.
